Superworth

Biotech stocks with the lowest EV/EBIT

What the whole business costs (market value plus debt, less cash) against operating profit over the last twelve months, one-off items taken out. As of .

Ranked
17
of 146 biotech stocks we cover
Median
18.8×
Lowest
4.7×
MGTX
Range
4.7× to 156×
median 18.8×
4.7×156×
#CompanyEV/EBITPEOperating marginMarket cap
1MGTXMeiraGTx4.7×13.1×46.3%$895.1M
2PLXProtalix BioTherapeutics7.5×11.1×28.9%$206.3M
3AGENAgenus8.2×n/m27.3%$294M
4ADMAAdma Biologics11.3×15.8×43.8%$2.5B
5UTHRUnited Therapeutics16.3×21.6×44.4%$25.9B
6EXELExelixis16.8×22.1×39.9%$17.4B
7HALOHalozyme Therapeutics17.8×38.5×35.9%$14.6B
8NBIXNeurocrine Biosciences18.6×21.3×23.6%$14.8B
9REGNRegeneron Pharmaceuticals18.8×24.0×24.7%$100B
10ALNYAlnylam Pharmaceuticals19.2×26.7×20.8%$21.2B
11VRTXVertex Pharmaceuticals28.1×31.5×38.0%$137.1B
12INCYIncyte28.3×15.3×30.6%$24.3B
13KRYSKrystal Biotech40.1×37.1×44.9%$8.8B
14ONCBeOne Medicines40.2×63.2×15.1%$40.2B
15TECHBIO-TECHNE45.0×63.2×20.7%$11.4B
16VCELVericel110×88.1×6.0%$2.1B
17RGENRepligen156×237×8.2%$9.8B

Not ranked: 115 with a loss over the last year, 3 with not a meaningful number. 11 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

EV/EBIT for other groups

Other rankings of biotech stocks

The group